| Fund | Type | Gross assets | Min. |
|---|---|---|---|
| Rpi US Partners 2019, LP | Private Equity | $1.69B | — |
| Rpi International Partners 2019, LP | Private Equity | $22M | — |
| Name | Title | Ownership | Since |
|---|---|---|---|
| Arthur Richard McGivern | Executive Vice President And General Counsel | Under 5% | 2025 |
| Carolyn Judith Rubin | Chief Compliance Officer | Under 5% | 2025 |
| George Wingate Lloyd Control | Executive Vice President And Chief Legal Officer | Under 5% | 2025 |
Royalty Pharma Sub-Manager, LLC reports $17.6 billion in regulatory assets under management on its Form ADV.
Royalty Pharma Sub-Manager, LLC manages 2 private funds with combined gross assets of $1.7 billion.
Royalty Pharma Sub-Manager, LLC reports 95 employees.
Royalty Pharma Sub-Manager, LLC is based in New York, NY and has been SEC-registered since 2025.
Royalty Pharma Sub-Manager, LLC is not required to publicly disclose fund returns. Form ADV filings include assets, ownership, and service providers, shown above.
| Address | 110 East 59th Street, New York, NY 10022 |
| Phone | 212-883-0200 |
| Office hours | 9:00a.m. - 6:00p.m. |
| SEC region | New York Regional Office (NYRO) |
| Discloses disciplinary history | No |
| Discretionary | $17.63B |
| Non-discretionary | $0 |
| Total (RAUM) | $17.63B |